India’s Sun Pharma Reviews Global Targets While Close Competitor Cipla Eyes Gains From Expansion
This article was originally published in PharmAsia News
Executive Summary
While keeping an eye on acquisition opportunities, India’s top drug makers stay firm on charting an international roadmap as product filings swell.